The largest energy consumer in the cell is the ribosome biogenesis whose aberrancy elicits various diseases in humans. It has been recently revealed that p53 induction, along with cell cycle arrest, is related with abnormal ribosome biogenesis, but the exact mechanism still remains unknown. In this study, we have found that aberrant ribosome biogenesis activates two parallel cellular pathways, c-Myc and ASK1/p38, which result in p53 induction and G1 arrest. The c-Myc stabilizes p53 by rpL11-mediated HDM2 inhibition, and ASK1/p38 activates p53 by phosphorylation on serine 15 and 33. Our studies demonstrate the relationship between these two pathways and p53 induction. The changes caused by impaired ribosomal stress, such as p53 induction and G1 arrest, were completely disappeared by inhibition of either pathway. These findings suggest a monitoring mechanism of c-Myc and ASK1/p38 against abnormal ribosome biogenesis through controlling the stability and activity of p53 protein.
Introduction
The ribosome is a large complex of ribonucleic acids and proteins responsible for translating the genetic information of mRNAs into polypeptides. The largest energy consumer among all biological processes in the cell is ribosome biogenesis. Many reports proved that the errors of progress in the ribosomal biogenesis were the cause of the various diseases. The inherited bone marrow failure syndromes representatively showed a close relationship between p53-mediated cell growth regulation and cellular responses to abnormality of ribosome synthesis (Liu and Ellis, 2006) . Interestingly, in zebrafish, it was suggested that aberrant ribosome biogenesis through the mutation of ribosomal genes has an oncogenic potential (Amsterdam et al., 2004) . In addition, a recent study showed that the enhanced progression of human breast tumor is induced by dysregulation of ribosome biogenesis and translational capacity (Belin et al., 2009) .
Studies have presently demonstrated that ribosome biogenesis is connected with the p53 activation pathway (Pestov et al., 2001; Opferman and Zambetti, 2006) . Ribosome biogenesis is initiated by ribosomal RNA (rRNA) synthesis and processing, followed by the assembly of rRNA with ribosomal proteins to make the ribosomal subunits. The activation of p53 is induced upon by the dysregulation of ribosomal and nucleolar proteins involved in ribosome biogenesis. If there are impaired functional proteins or factors interfering with rRNA processing at various steps, it can potentially provoke morphological changes of the nucleolus, quantitative changes in ribosomes and translation profile. It has been thought that aberrant ribosome biogenesis in the nucleolus induces p53 activation through different mechanisms (Boisvert et al., 2007) .
As a non-ribosomal protein, p14 ARF blocks rRNA transcription and processing when it is accumulated in the nucleolus, subsequently stabilizing p53 upon interaction with Mdm2 (Sherr, 2006) . In addition, inactivation of nucleoplasmin could inhibit rRNA processing and disrupt the integrity of the nucleolus, ultimately leading to acute myeloid lymphoma (Cazzaniga et al., 2005) .
The correlation between p53 and ribosomal proteins has been further established through recent studies. A surplus of free ribosomal proteins induced by ribosomal stress promotes their interaction with Mdm2 in the nucleoplasm. In case of rpL11, its neddylation has a role in necleolar p53 signaling in response to perturbation of ribosomal biogenesis (Sundqvist et al., 2009) . Ribosomal protein L11, L5, L23 and S7 have all been shown to bind the central domain of Mdm2 in response to ribosomal stress (Zhang and Lu, 2009 ). These interactions suppress Mdm2 E3 ligase activity against the degradation of p53 protein. Moreover, rpL26 was identified as a p53 translational activator as it can bind the 5 0 -UTR of p53 mRNA and increase translation (Takagi et al., 2005) . In contrast to the above described ribosomal proteins, there is another association between ribosomal protein (rpL26) and Mdm2 that differently regulates p53 protein level. Mdm2 can also bind to rpL26 protein and mediate rpL26 degradation by poly-ubiquitination. This attenuates the association of rpL26 with p53 mRNA and consequently suppresses p53 protein translation (Ofir-Rosenfeld et al., 2008).
Experiments using rpL22-deficient mice showed that the increase of p53 protein in T cells is caused by translational upregulation, and that ab-T cells specifically activate the cell cycle checkpoint in the absence of rpL22 (Anderson et al., 2007) . Furthermore, it was shown that conditional knockout of rpS6 in the thymus causes failure of T-cell development (Sulic et al., 2005) because of the activation of a p53-dependent checkpoint rather than a defect in protein translation. Another report showed that the activation of p53 by rpS6 depletion resulted in the construction of a rpL11-Mdm2-p53 circuit dependent upon 5 0 -TOP mRNA translation (Fumagalli et al., 2009) .
In this paper, we investigated the precise mechanism of p53 activation due to impaired ribosome biogenesis through rpS3 knockdown, and identified that two signaling pathways, c-Myc and ASK1/p38, are closely related to the induction and activation of p53 both in cancer and normal cells. Therefore, we suggest a general surveillance mechanism mediated by p53 for impaired ribosome biogenesis.
Results
p53 induction caused by rpS3 knockdown is mediated by post-translational control To determine whether rpS3 knockdown potentially induces ribosomal stress, we first checked the protein level of p53 in HT1080 cells transfected with siRNA against control or rpS3 (siRPS3-203 and siRPS3-635) (Kim et al., 2009) . We observed that the protein levels of p53 and p21 were dramatically increased by rpS3 knockdown (Figure 1a) . We also confirmed that p53 induction is occurred in the nucleus by both nuclear/ cytosol fractionation (Supplementary Figure S1A) and immunostaining ( Figure 1b) . We next examined the regulation step, which affects p53 induction because the level of p53 protein is regulated by transcription, translation or post-translational modification. We observed that neither transcription nor translation step is not involved in p53 induction caused by rpS3 knockdown (Supplementary Figures S1B and C) . Finally, we tested whether p53 induction is mediated by (a) HT1080 cells were treated with or without siRNAs against control and rpS3, si203 and si635, respectively. After 48 h, cell extracts were resolved using 10% sodium dodecyl sulfate-PAGE and subjected to immunoblot analysis using the indicated antibodies. (b) HT1080 cells were transfected with siRNAs as indicated. After 48 h, cells were fixed and immunostained with rpS3 (green) and p53 (red) antibodies. (c) Cell extracts obtained from siRNA-transfected cells were pretreated with MG132 (10 mM, 6 h) and immunoprecipitated with p53 antibody. Total-cell extracts (left) and p53 immunoprecipitates (right) were resolved and subjected to immunoblot analysis using the indicated antibodies. (d) Control or rpS3-knockdown HT1080 cells were fractionated in a linear sucrose gradient as described in Materials and methods. Polysome, monosome (80S) and ribosomal subunits (40S, 60S) regions were marked in the ribosome profile (upper). Each fraction obtained in the upper panel was resolved by 12% sodium dodecyl sulfate-PAGE and subjected to immunoblot analysis using rpS3, rpL11 and ERK antibodies (lower). ERK was used as a marker protein for the soluble fraction. (e) Equal amounts of total RNA were loaded onto a 1% formaldehyde agarose gel and cell extracts were subjected to immunoblot analysis using rpS3 antibody (left), and the total RNA was subjected to northern blot analysis. The nylon membranes were hybridized with ITS-1 and ITS-2 oligonucleotide probes (right).
The surveillance mechanism of ribosomal stress HD Kim et al a post-translational step using MG132, a proteasome inhibitor. As shown in Supplementary Figure S1D , p53 was markedly increased by MG132 treatment compared with untreated control, indicating that p53 induction caused by rpS3 knockdown is regulated by a posttranslational step. To strengthen this, we examined the level of p53 ubiquitination and observed that rpS3 knockdown resulted in the simultaneous upregulation of p53 and HDM2, a target protein of p53, (Figure 1c , left) and the downregulation of p53 ubiquitination compared with control cells (Figure 1c, right) . Furthermore, we confirmed that p53 stability is increased more in rpS3-knockdown cells than in control cells (Supplementary Figure S1E ).
RpS3-knockdown exhibits aberrant ribosome biogenesis
In previous reports, the downregulation of ribosomal proteins was shown to affect ribosome biogenesis, producing an abnormal ribosome profile (Idol et al., 2007; Robledo et al., 2008) . Therefore, we analyzed the ribosome profile. As shown in Figure 1d , rpS3 knockdown caused an abnormal ribosome profile showing significant changes in 80S monosome and 60S subunit peaks. Immunoblot analysis also showed that rpS3 knockdown decreased the amount of rpS3 in 40S subunit, and decreased the amount of rpL11 in 80S monosome, but increased the amount of rpL11 in 60S subunit ( Figure 1d ). However, the total level of rpL11 was not changed by rpS3 knockdown (Supplementary Figure S2) . Next, we checked rRNA processing, as ribosome biogenesis is involved in the sequential processing of pre-rRNA (Fromont-Racine et al., 2003; Granneman and Baserga, 2004) . RpS3 knockdown raised a significant diminution of 18S rRNA (Figure 1e , left) and, in particular, an extensive accumulation of 30S and 32S pre-rRNA intermediates (Figure 1e , right). These results coincided with previous reports that characterized the depletion affects the rRNA processing by various siRNAs against ribosomal proteins (Gazda et al., 2008; Robledo et al., 2008) . These data collectively indicate that rpS3 depletion actually induces ribosomal stress.
RpS3 depletion induces both p38 activation and p53 phosphorylation Thus far, we have confirmed that rpS3 knockdown leads to p53 induction and impaired ribosome biogenesis ( Figure 1 ). To explore the relationship between these two phenomena, we first checked the activation status of mitogen-activated protein kinase family because mitogen-activated protein kinases, especially c-Jun NH 2 -terminal kinase, were reported to be activated by a ribotoxic stress response (Iordanov et al., 1997; Laskin et al., 2002) . Interestingly, we only detected p38 activation, but not either c-Jun NH 2 -terminal kinase or ERK, in rpS3 depleted cells ( Figure 2a ). Next, we investigated the phosphorylation status of p53 because it may be involved in both stabilization and activation of p53. We identified two serine residues, serine 15 and serine 33, that are remarkably phosphorylated by rpS3 knockdown (Figure 2b ). These data lead to the speculation that the p38-dependent phosphorylation is involved in the p53 induction, since it has been demonstrated previously that the phosphorylation at these sites is regulated mainly by p38 kinase (Bulavin et al., 1999; Lavin and Gueven, 2006) , and has an effect on the stability and activity of p53 (Bulavin et al., 1999; Kishi et al., 2001) .
The phosphorylation status of p53 is specifically regulated by p38 activity To confirm the relation between p38 and p53 phosphorylation, we investigated p53 induction and phosphorylation using inhibitor or siRNA against p38. HT1080 cells, transfected with control or rpS3 siRNA, were treated with p38 inhibitor, SB202190 (Supplementary Figure S3) . SB202190 abrogated the p53 induction caused by rpS3 knockdown by more than 50%, and also mostly diminished the p53 phosphorylation on serines, even though the phosphorylation on serine 15 was slightly decreased (Supplementary Figure S3 ).
To strengthen this result, we performed a similar experiment using p38 siRNA ( Figure 2c ). This result was in a good agreement with the effect of p38 inhibitor in that both p53 and p-p53 were downregulated in rpS3 and p38 double-knockdown cells. Interestingly, a more prominent diminution of phosphorylation on serine 15 was observed. These data suggest that the ribosomal stress caused by rpS3 knockdown activates p38, thus stabilizing p53 protein by p38-dependent phosphorylation.
Impaired ribosome biogenesis affects p53-dependent cell cycle arrest
We demonstrated that knockdown of rpS3 induces p53 activation through p38. The p53 protein is a well-known regulator of cell proliferation (Ullrich et al., 1992) and cell cycle checkpoints (Giono and Manfredi, 2006 ). Therefore, we tested whether rpS3 knockdown affects cell proliferation and cell cycle progression by [ 3 H]-thymidine uptake and FACS analysis, respectively. RpS3 depletion significantly decreased thymidine incorporation about 40% in comparison with control cells (Figure 2d) , and also changed the cell cycle status that displays about 20% increase in G1 arrest in rpS3 knockdown cells, whereas the cell populations in S and G2/M phases were decreased (Figure 2e ). The same result was obtained from HCT116 cells. G1 arrest occurred only in HCT116 p53 wild-type (p53
), as expected (Supplementary Figure S4 ). These clearly show that the G1 arrest caused by impaired ribosome biogenesis is a p53-dependent event.
RpS6 knockdown shows the similar effect as rpS3 knockdown To expand and confirm our findings, we also added two siRNAs against 40S ribosomal proteins, rpS6 and RACK1. And we compared with our previous results from rpS3 knockdown. As expected, rpS6 knockdown, but not RACK1, induced the diminution of newly synthesized proteins as the same as rpS3 knockdown (Supplementary Figure S5A) . We also identified that p53 induction and p38 phosphorylation are only induced by rpS6, but not RACK1 siRNA (Figure 3a ). Moreover, the translational level of p53 in all siRNAtransfected cells did not change as previously shown in Supplementary Figure S1B (Supplementary Figure S5B) . The results produced by RACK1 depletion can be interpreted as the same as the previous report showing that RACK1 is associated with ribosome in the cytoplasm at the final stage of the ribosome biogenesis, such as rpS15, or is not essential for the function of 40S small subunit such as rpS25 (Robledo et al., 2008) . Finally, we checked ribosome profiles using a linear sucrose gradient as described in Materials and methods. The knockdown of the ribosomal proteins altered the ribosome profiles, but no change was seen in control or RACK1 siRNA-transfected cells (Figure 3b ). RACK1 depletion showed only a slight diminution of the 80S monosome peak, compared with rpS3 or rpS6 knockdown displaying the reverse pattern for both the 80S and 60S peaks. Altogether, these data suggest that the depletion of most ribosomal proteins induces impaired ribosome biogenesis as well.
Depletion of p38 kinase abrogates G1 arrest caused by ribosomal stress As shown in Figure 3c , we confirmed the nuclear co-localization of p53 and p38 using immunostaining in rpS3 or rpS6 knockdown cells (Figure 3c ). To investigate whether p38 is necessary for p53-mediated G1 arrest in the ribosomal stress condition, cell cycle status was analyzed by flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). As shown in Figure 3d , G1 arrest was induced by either rpS3 or rpS6 siRNA, but it was not shown in combination with p38 siRNA. These results suggest that p53 function in cell cycle regulation is closely connected with p38-dependent phosphorylation.
p53 induction is closely related with c-Myc protein We next explored why p53 is upregulated in cells with impaired ribosome biogenesis. We marked a change in the protein level of c-Myc because it is a well known regulator of ribosome biogenesis (Dai and Lu, 2008) . Interestingly, the level of c-Myc protein was decreased by rpS3 or rpS6 knockdown, but not RACK1 (Figure 4a ). To verify whether p53 induction is related with c-Myc, we introduced c-Myc siRNA into HT1080 cells in combination with siRNAs against ribosomal proteins. Upregulation of p53 induced by either rpS3 or rpS6 knockdown was blocked by c-Myc siRNA co-treatment (Figure 4b ). These data show a common feature of c-Myc reduction in rpS3 or rpS6 knockdown cells. Therefore, we examined the feedback regulation of c-Myc by p53 as was identified previously (Cleveland and Sherr, 2004) , and confirmed that p53 overexpression reduces the level of c-Myc protein (Supplementary Figure S6A) . Moreover, we checked the phosphorylation status of p53 in cells transfected with several siRNAs (Supplementary Figure S6B ). The induction and phosphorylation level of p53 carried by rpS3 or rpS6 knockdown were decreased by combinational knockdown of either p38 or c-Myc, respectively. These results indicate that p53 function, in the ribosomal stress, is also regulated by c-Myc just like p38. Next, we examined whether p14 ARF expression is induced by The surveillance mechanism of ribosomal stress HD Kim et al ribosomal stress, because p14 ARF is a well-known regulator of p53 by inactivating HDM2 (Stott et al., 1998) . Upregulation of p14 ARF was detected in rpS3 or rpS6 knockdown cells both by immunoblotting (Supplementary Figure S7A ) and immunostaining (Supplementary Figure S7B ). Furthermore, we chased the marked changes of p53, c-Myc and p14 ARF in a timedependent manner, and confirmed the protein levels of p53 and p14 ARF were increased whereas that of c-Myc was decreased by rpS3 or rpS6 knockdown (Figure 4c , Supplementary Figure S8 level, we demonstrated the effect of p14 ARF and rpL11 knockdown on the aberrant ribosome biogenesis. Only, rpL11 knockdown decreased the p53 level in the aberrant ribosome biogenesis (Figure 4d) . Although the increased level of rpL11 in nucleoplasm was not confirmed, we could contemplate the possibility through the co-immunoprecipiaton experiment (Supplementary Figure S9) . In spite of MG132 treatment, the level of c-Myc was not recovered (Supplementary Figure S10) . This result indicates that the translational level of c-Myc is decreased in the late stage of aberrant ribosome biogenesis.
ASK1 participates in p53-dependent cell cycle arrest as a p38 upstream kinase To define an upstream regulator of p38 kinase, the expression level of several proteins was analyzed in siRNA-transfected cells. Interestingly, we observed an increased ASK1 activity even though the level of ASK1 is decreased in rpS3 or rpS6 depleted cells (Supplementary Figure S7C ). Therefore, we performed ASK1 knockdown experiments in combination with control, rpS3 or rpS6 siRNAs, and immunoblotting was followed. The pattern of all proteins was coincided with our previous data. ASK1 knockdown blocked not only p38 activation, but also p53 induction and phosphorylation (Figure 4e) . We also checked cell cycle distribution in that condition ( Figure 4f ). As expected, G1 cell cycle arrest caused by ribosomal stress was not shown in ASK1 knockdown cells. These results suggest that ASK1 functions as an upstream regulator upon ribosomal stress, and affects p53-dependent G1 cell cycle arrest.
The cellular response to ribosomal stress is a general phenomenon So far, we have investigated the cellular response to ribosomal stress in cancer cell lines. To identify whether normal cells show the similar effect upon ribosomal stress, we used two normal cells, F65 normal human fibroblasts and mouse embryonic fibroblasts. F65 cells showed an increase in the level of p53 protein and phosphorylated p38 (Figure 5a ). However, these effects were disappeared by p38 knockdown. We also checked cell cycle progression using rpS3 or rpS6 siRNAs in combination with p38 or ASK1 siRNA. G1 phase arrest induced by rpS3 or rpS6 single-knockdown was abrogated by double-knockdown with either p38 or ASK1 (Figure 5b ). These results were coincided with our previous data obtained from HT1080 cancer cells. Moreover, we confirmed the identical results using mouse embryonic fibroblasts (Supplementary Figures  S11A and B) . Next, we used the low concentration of actinomycin D, which is known to block not transcription, but ribosome biogenesis (Supplementary Figure  S12) . Interestingly, the levels of p53 and phospho-p38 also increased in the actinomycin D-treated samples, but the level of endogenous p14 ARF was not accumulated. As the intact large ribosomal subunit exists in the aberrant small ribosomal subunit biogenesis, we supposed that the signal from actinomycin D (disrupt biogenesis of two ribosomal subunits) is not the same as the signal from single ribosomal protein knockdown. Finally, we verified that p53 protein level did not change in c-myc, p38 and ASK1 knockdown cells (Supplementary Figure S13) .
Altogether, these results demonstrate that the cellular response to ribosomal stress is a general phenomenon in both normal and cancer cells.
Discussion
Here, we have investigated the relationship between impaired ribosome biogenesis and p53-dependent cell cycle arrest using siRNAs against small ribosomal proteins. Ribosome biogenesis is very well tuned, thus a depletion of one ribosomal protein causes a simultaneous reduction of the other ribosomal proteins belonging to the same subunit. Therefore, it is possible that the p53 induction mediated by ribosomal stress may be differently regulated according to the defect in either 40S or 60S subunit.
It was previously demonstrated that disruption of 60S subunit induces p53 stabilization by surplus of ribosomal proteins through either suppression of Mdm2-mediated p53 degradation or promotion of p53 mRNA translation. Even though it can be described as the ribosomal stress-induced p53 activation in late stage, it is not enough to understand detailed and unique cellular responses mediated by impaired ribosome biogenesis. Our studies presented here suggest that the induction mechanism of p53 is simultaneously regulated by two different signaling pathways, c-Myc and ASK1/p38. Each pathway functions in the Mdm2 inhibition and p53 activation through inducing free rpL11 and p53 phosphorylation, respectively.
Depletion of 40S ribosomal proteins, in general, causes an imbalance between 40S and 60S subunit in the ribosome pool, which may result in the accumulation of 60S large subunit because it no longer can assemble into the 80S monosome. In response to ribosomal stress, free RPs are known to be continuously released from the nucleolus to the nucleoplasm. Accordingly, we checked the possibility that free rpL11 interacts with mdm2 to stabilize p53. However, we could not detect the changed level of non-ribosomal and ribosomal rpL11 in cells transfected with rpS3 siRNA (Figure 1d, Supplementary Figure S2) . It is probably, because ribosomal proteins are abundant proteins, it is possible that the amount of rpL11 is subtly changed in the nucleus. Moreover, we have verified both p14 ARF upregulation (Figure 4c ) and p53 phosphorylation (Figures 2 and 3) , which affect the p53 stabilization. Interestingly, the association of rpL11 with mdm2 increased in the cells as well as p14 ARF (Supplementary Figure S9 ). But, we did not detect HDM2 protein in the immunoprecipitatants of rpL11, because the large amount of rpL11 exists in the ribosome complex and only the small amount of the extraribosomal rpL11 will be present. In addition, we checked the effect of p14 ARF knockdown in the aberrant ribosome biogenesis (Figure 4d ). But, contrary to our expectation, the p53 level was not decreased. This result is consistent with the recent data showing that p14 ARF -independent p53 pathway exists in ribosomal stress condition (Macias et al., 2010) .
As rpL11 increases in the translational level in response to nucleolar/ribosomal stress, we suppose that the early activated c-myc will transduce the signal to the expression of L11 (Fumagalli et al., 2009) . Subsequently, increased rpL11 will be also involved in the p53 activation and negatively regulate the level of c-myc. This supposition is the same as the previous report, which RPL11 acts as a feedback regulator of c-Myc (Dai et al., 2007) . In Figure 4d , rpL11 knockdown partly decreased the p53 level in the aberrant ribosome biogenesis. Although the increased level of extraribosomal rpL11 in nucleoplasm was not confirmed, we could contemplate the possibility through HDM2 immunoprecipiaton experiment. In addition, the level of c-Myc was not recovered in spite of MG132 treatment (Supplementary Figure S10) . Therefore, we suppose that the translational level of c-Myc is decreased in the late stage of serious aberrant ribosome biogenesis. Namely, the p53/rpL11 feedback inhibition appears to be started within 12 h following the treatment of siRNA. Accordingly, reduction of the overexpressed rpL11 will be able to decrease the p53 level. We also suggest that the c-Myc is activated by a sensing mechanism in the early stage of S3 or S6 knockdown, and the activated c-Myc is rapidly degraded. Taken together, it appears that p53 induction is mediated not only by Mdm2 inhibition through association with ribosomal proteins, but also by increased phosphorylation of p53.
Our studies show that aberrant ribosome biogenesis specifically activates only p38, but not c-Jun NH 2 -terminal kinase or ERK (Figure 2a) . We also verified that ASK1 is an upstream regulator of p38 activation (Figures 4e and 5b) . Despite the decreased expression, the increment of activity was detected by ASK1 kinase assay (Supplementary Figure S7C) . As most of ribosomal proteins are highly basic, they may have a function of controlling the intracellular redox state. Therefore, we supposed that ASK1 activation in aberrant ribosomal biogenesis is triggered by reactive oxygen species generation (Sumbayev and Yasinska, 2005) . We also demonstrated that aberrant ribosome biogenesis elicits both p38 activation and p53 phosphorylation at serines 15 and 33 (Figure 2c ). Although several lines of evidence showed p38-mediated p53 activation and stabilization through direct phosphorylation of critical residues (Bulavin et al., 1999; Bode and Dong, 2004) , it is possible that p53 was activated by an alternative pathway because p53 phosphorylation of serine 15, comparing with serine 33, was not remarkably abolished after p38 inhibition through either inhibitors or siRNA. Therefore, we cannot exclude the possibility that serine 15 phosphorylation is affected by unknown kinases responsible for ribosomal stress.
According to the previous studies, c-Myc is an important factor both in the ribosome biogenesis and the p53 stabilization (Menne et al., 2007; Dai and Lu, 2008) . Our data also suggest that c-Myc affects the stabilization of p53 through rpL11-mediated HDM2 inhibition, but not p14 ARF . We have examined that the protein levels of p53 and p14 ARF were increased by aberrant ribosome biogenesis, whereas the level of cMyc protein was somewhat decreased unexpectedly ( Figure 4) . However, p53 induction was abolished by knockdown of c-Myc, indicating that c-Myc activity is necessary to stabilize p53 protein. Interestingly, recent studies have shown that ribosomal protein haploinsufficiency suppresses the activity of c-Myc (Barna et al., 2008) . In conjunction with our results, this suppression of c-Myc activity may be caused by reduced level of c-Myc. Furthermore, the feedback inhibition mechanism, such as p53-mediated c-Myc and p14 ARF and p14 ARF /rpL11-mediated c-Myc, is correlated with c-Myc downregulation (Cleveland and Sherr, 2004; Ho et al., 2005) . Therefore, we assumed that downregulation of c-Myc protein occurred in concert with upregulation of both p14
ARF and p53 proteins in the ribosomal stress. Taken together with recent reports, our results strongly suggest a model described in Figure 5c . The p53 induction by impaired ribosome biogenesis is contributed by two different pathways; first, the c-Myc/rpL11 pathway is activated in the early stage of mild aberrant ribosomal biogenesis probably in the nucleus. Second, ASK1-p38 pathway is activated in the late stage of serious aberrant ribosomal biogenesis. We also suggest that the late stage is caused by abnormal cytosolic ribosomal stress. Then, the ASK1 may be activated by the cytosolic ribosomal stress, such as reactive oxygen species induction and ER stress, and it is thought that these pathways have a synergistic effect on the p53 stabilization.
Aberrant ribosome biogenesis elicits neoplastic transformation while simultaneously causing various diseases (Ruggero and Pandolfi, 2003; Maggi and Weber, 2005) . Many researchers suggest that the altered translational ability of ribosome as well as the extra-functions of ribosomal proteins elicits disease outbreak (Zimmermann, 2003) . Specifically, alteration of ribosomal translational ability results in the specific increase of mRNA translation for genes, such as 5 0 -TOP, tumor suppressor gene and oncogene mRNA (Fumagalli et al., 2009) .
Currently, only two cases of ribosomapathy have been reported that led to diseases because of mutated mammalian ribosomal proteins. The first case is the mutated rpL24 gene, which is found in the Belly spot and tail (Bst) mouse. The mutation impairs the splicing of rpL24 mRNA and protein production, and is also associated with altered ribosome biogenesis (Oliver et al., 2004) . However, this has not yet proposed as a human disease model. The second case is the rpS19, which has been found as a null mutant in a quarter of patients with Diamond Blackfan anemia (DBA). Apart from rpS19, the alterations of rpS17 and rpS24 have also been identified in patients with DBA (Ellis and Lipton, 2008) . In addition, mutations in rpL5, rpL11 and rpL35a of the 60S ribosomal subunit have been identified in several DBA patients (Gazda et al., 2008) . Although its etiology is unclear, it has been revealed that defects in both 18S rRNA processing and maturation of the 40S small subunit could cause problems for protein synthesis. As the association of rpL5 or rpL11 with Mdm2 blocks the degradation of p53, p53-induced cell cycle arrest in erythroid progenitor cells is probably mediated by the same preceding mechanism. However, for rpL23 and rpS7, which also participate in the Mdm2-mediated p53 degradation pathway, no mutations have been identified in DBA patients. Therefore, p53 induction in DBA patients is caused more by an incongruity of rpL5 and rpL11 during ribosome biogenesis than their interaction with Mdm2.
In this study, we demonstrated that the induction mechanism of p53 through nucleolar stress is dependent on p38 activation using p38 inhibitors and siRNA. Just as p38 inhibitor is being used in clinical therapies for multiple myeloma, the inhibition of p38 also could provide medical treatments for ribosome-linked diseases, such as DBA, X-linked dyskeratosis congenita and Treacher Collins syndrome.
Materials and methods
Cell fractionation and ribosome pelleting Cellular fractionation of the nucleus and cytosol as well as ribosome-pelleting using a sucrose cushion were performed as previously described (Kim et al., 2006 (Kim et al., , 2009 .
